🇺🇸 FDA
Patent

US 9180144

Decellularisation of tissue matrices for bladder implantation

granted A61KA61K35/22A61P

Quick answer

US patent 9180144 (Decellularisation of tissue matrices for bladder implantation) held by Tissue Regenix Limited expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Tissue Regenix Limited
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K35/22, A61P, A61P13/10, A61P17/02